The Institute owes tremendous gratitude to Professor Peter Gray for his courage and dedication to join UQ and establish this incredible lasting legacy. I am excited to step into this role with the foundations well and truly established; the people in place, the research programs developed and infrastructure built. There are a great – and ever increasing – number of people who owe their careers and livelihoods to AIBN, and I hope Professor Gray takes great satisfaction in what he has achieved.
Coming to AIBN with my external perspective from the Radboud University Nijmegen, Netherlands, in my opinion the Institute’s greatest strengths are its dedication to applied research outcomes and the breadth and scope of the work undertaken. They are a truly unique and remarkable combination. I look forward to cultivating those strengths and building upon them.
I would like to particularly recognise the work of the AIBN Board, which has been ably chaired by Euan Murdoch, and fellow Board members Kathy Hirschfeld, Chris Lowe, Bob McCarthy, Susan Pond and Robyn Ward. Additionally, I would like to acknowledge the efforts and direction provided by the Scientific Advisory Board.
The support of the greater University of Queensland also deserves our thanks. Since my arrival to this university I have been pleased to see the collaborative nature UQ shares across its institutes, schools, centres and faculties, which I intend to further explore. The leadership of Professor Peter Høj (Vice-Chancellor and President), together with Professor Joanne Wright (Provost (Acting)), Professor Robyn Ward (Vice-Chancellor (Research)) and Professor Anton Middelburg (Pro-Vice-Chancellor (Research and International)) has been pivotal in the success of the university in recent years, and fostering an environment in which AIBN has been able to thrive.
I look forward to a future in which AIBN will continue to turn ground breaking science into innovative applications, from advanced materials and diagnostic tools, to cures for important diseases and many more.
Close cooperation with medical professionals and industries will be key to achieving such goals, as is providing promising young academics with the entrepreneurial skills required to turn cutting edge science into successful products. The foundations for a dynamic AIBN, recognised around the world, have been laid. Now it is my challenge to enable it.
Professor Alan Rowan
AIBN Director